Impact of the implementation of a double blind placebo controlled provocation elimination test in the management of (suspected) cow milk protein allergy (CMPA) in infants.
- Registration Number
- NL-OMON20340
- Lead Sponsor
- Department of pediatrics, Atrium medical center
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. Patients referred by a pediatrician, general practioner or infant welfare clinic physician (consultatiebureau art) with a suspected cow milk protein allergy;
2. Patients younger under the age of 2 years;
Exclusion Criteria
Patients in whom a previous diagnosis of cow milk protein allergy has been made and needs to undergo a repeat chalenge test or in whom there has been a proven tolerance to cow milk protein.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method